May 18, 2022

Starpharma’s (ASX:SPL) antiviral agent fights back against against influenza virus

Starpharma’s (ASX:SPL) antiviral agent fights back against against influenza virus

The Market Herald reports on Starpharma’s SPL7013 agent, which achieved up to 99.7 per cent reduction in viral activity against two types of influenzas virus. Read the article here.

 This contains certain forward-looking statements.